Swedish medical technology company RaySearch Laboratories AB (publ) (STO:RAY-B) announced on Tuesday that it has received an order from Heyou Hospital in Foshan City, Guangdong Province, China, for the RayStation treatment planning system.

The total value of the order, including a service contract, is RMB51m (approximately SEK77m), with RMB18m (approximately SEK26m) expected to be recognized in Q1 2025. This marks RaySearch's third-largest order and the largest since December 2022. Heyou Hospital is the first customer to use both a Hitachi carbon ion and proton machine alongside RayStation for treatment planning.

Heyou Hospital, known for its focus on personalized healthcare and research, purchased the combined Hitachi machine in 2021. RayStation will complement this with advanced treatment planning capabilities for both particle and conventional photon therapies. The integration of ion beam therapy, which offers more precise tumour targeting and reduced side effects, further strengthens RaySearch's position in the growing Chinese market for particle treatments. RayStation's advanced technologies include pencil beam scanning, robust optimization and GPU-accelerated dose calculations, enhancing treatment precision and efficiency.

(EUR1=RMB7.16)

(EUR1=SEK11.09)